lutetium (177Lu)-edotreotide

lutetium (177Lu)-edotreotide
Trade Name
Orphan Indication Gastro-entero-pancreatic neuroendocrine tumors
USA Market Approval USA
USA Designation Date 2015-05-21 00:00:00
Sponsor ITM Solucin GmbH;Lichtenbergstrasse 1, 85748 Garching;
Related Access Program
Advanced Accelerator Applications – Neuroendocrine Tumors Andrei Iagaru – Other Neuroendocrine Tumors Jonsson Comprehensive Cancer Center – Neuroendocrine Tumors Memorial Sloan Kettering Cancer Center. – Neuroendocrine Tumors